Live News EQUITY M impact Jun 22, 2026, 01:13 PM UTC

RMD: Keybanc Maintains Overweight

Keybanc maintains overweight rating on ResMed and lowers price target to $266

SQUAWKNEWS Updated Jun 22, 2026, 01:15 PM UTC

Keybanc Maintains Overweight on ResMed, Lowers Price Target to $266